A therapy at the center of their $22 billion alliance failed to extend survival in a type of lung tumor, leading the ...

The Company’s expansion efforts come amid an increase in the global focus on scalable respiratory solutions, which may position the Company as a strtegic platform for public health initiatives and ...

Merck (MRK) stock falls as the company withdraws U.S. marketing application for lung cancer therapy HER3-DXd developed with ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

Roche said on it would advance testing of an antibiotic against a common drug-resistant bacteria that causes serious hospital infections into the third and last phase of testing on humans.

for doxycycline 100 mg dispersible tablets under the Chemical and Allied Products category (Product Code 'A'). Doxycycline is used to treat bacterial infections in many different parts of the body. It ...

PASADENA, Calif, March 27, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology ... used for working capital and other general corporate purposes. Study published in Cancer Discovery, revealing that LB ...

She saw how her parents started their biotech company ... “We have a 100-acre food park in Malur outside Bengaluru, which features a cryogenic grinding facility that uses liquid nitrogen at ...

The study focused on individuals with the highest doxycycline use. The participants were randomized 2:1 to receive doxy-PEP (n = 100) or standard care (n = 50). Rectal swabs were self-collected at ...

Taking a dose of the oral antibiotic doxycycline after a high-risk sexual encounter ... in the Division of Infectious Diseases at UCSF. The study included 100 individuals who used doxy-PEP and 50 ...

Taking a dose of the oral antibiotic doxycycline after a high-risk ... The study included 100 individuals who used doxy-PEP and 50 individuals who received standard-of-care and did not use doxy ...